← Every lobbying firm
Tarplin, Downs & Young, LLC
A registered lobbying firm, and the clients it files for. Everything here comes from the quarterly disclosures it is required to make under the Lobbying Disclosure Act. Filed as TARPLIN, DOWNS & YOUNG, LLC.
Clients
27
named in its filings
Filings
51
2026
Fees reported
$3.3M
across every filing
Who it represents
Largest first, by what the filings report being paid.
| Client | Fees |
|---|---|
| Astellas Pharma US, IncAstellas Pharma Inc | $240K |
| Jazz Pharmaceuticals Inc.Jazz Pharmaceuticals PLC | $240K |
| Neurocrine Biosciences, Inc.Neurocrine Biosciences Inc | $190K |
| Sarepta TherapeuticsSarepta Therapeutics Inc | $180K |
| Elevance Health, IncElevance Health Inc | $160K |
| Novocure Inc.Novocure Ltd | $160K |
| Vertex Pharmaceuticals IncorporatedVertex Pharmaceuticals Inc | $160K |
| Amazon.com Services LLCAmazon.com Inc | $160K |
| Option Care HealthOption Care Health Inc | $160K |
| AstrazenecaAstraZeneca PLC | $160K |
| Actum On Behalf Of Healthequity, Inc.Healthequity Inc | $130K |
| LantheusLantheus Holdings Inc | $120K |
| PhreesiaPhreesia Inc | $120K |
| GentivaHumana Inc | $120K |
| Crinetics PharmaceuticalsCrinetics Pharmaceuticals Inc | $120K |
| Quest DiagnosticsQuest Diagnostics Inc | $120K |
| Novo Nordisk Inc.Novo Nordisk A/S | $120K |
| Sanofi US Services IncSanofi SA | $120K |
| Abbvie Inc.AbbVie Inc | $120K |
| Cardinal HealthCardinal Health Inc | $96K |
| Amylyx PharmaceuticalsAmylyx Pharmaceuticals Inc | $80K |
| Gilead Sciences, Inc.Gilead Sciences, Inc | $80K |
| Amgen Inc | $60K |
| Eli Lilly And CompanyEli Lilly and Co | $60K |
| MerckMerck & Co Inc | $50K |
| Accenture Federal ServicesAccenture PLC | $20K |
| BDBecton Dickinson and Co | — |
Every filing
Newest first, and within a year the largest.
| Client | Fee |
|---|---|
| Neurocrine Biosciences, Inc. | $110K |
| Sarepta Therapeutics | $90K |
| Sarepta Therapeutics | $90K |
| Elevance Health, Inc | $80K |
| Novocure Inc. | $80K |
| Vertex Pharmaceuticals Incorporated | $80K |
| Novocure Inc. | $80K |
| Astellas Pharma US, Inc | $80K |
| Astellas Pharma US, Inc | $80K |
| Amazon.com Services LLC | $80K |
| Jazz Pharmaceuticals Inc. | $80K |
| Jazz Pharmaceuticals Inc. | $80K |
| Neurocrine Biosciences, Inc. | $80K |
| Option Care Health | $80K |
| Vertex Pharmaceuticals Incorporated | $80K |
| Jazz Pharmaceuticals Inc. | $80K |
| Gilead Sciences, Inc. | $80K |
| Amazon.com Services LLC | $80K |
| Option Care Health | $80K |
| Astellas Pharma US, Inc | $80K |
| Cardinal Health | $80K |
| Astrazeneca | $80K |
| Astrazeneca | $80K |
| Elevance Health, Inc | $80K |
| Lantheus | $60K |
| Phreesia | $60K |
| Phreesia | $60K |
| Gentiva | $60K |
| Gentiva | $60K |
| Crinetics Pharmaceuticals | $60K |
| Quest Diagnostics | $60K |
| Amgen Inc | $60K |
| Novo Nordisk Inc. | $60K |
| Quest Diagnostics | $60K |
| Sanofi US Services Inc | $60K |
| Abbvie Inc. | $60K |
| Eli Lilly And Company | $60K |
| Novo Nordisk Inc. | $60K |
| Sanofi US Services Inc | $60K |
| Lantheus | $60K |
| Crinetics Pharmaceuticals | $60K |
| Abbvie Inc. | $60K |
| Actum On Behalf Of Healthequity, Inc. | $50K |
| Merck | $50K |
| Amylyx Pharmaceuticals | $40K |
| Amylyx Pharmaceuticals | $40K |
| Actum On Behalf Of Healthequity, Inc. | $40K |
| Actum On Behalf Of Healthequity, Inc. | $40K |
| Accenture Federal Services | $20K |
| Cardinal Health | $16K |
| BD | — |
Source: quarterly LD-2 disclosures filed under the Lobbying Disclosure Act. A fee covers everything the firm did for that client in the period, so it cannot be attributed to any one issue on the list. A filing that states no figure contributes nothing rather than a zero. Clients with no ticker are kept: a trade association or a foreign ministry is as much a part of what the firm does as a listed company.